New York State Common Retirement Fund Reduces Holdings in Definitive Healthcare Corp. (NASDAQ:DH)

New York State Common Retirement Fund reduced its position in Definitive Healthcare Corp. (NASDAQ:DH) by 1.1% in the first quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 763,367 shares of the company’s stock after selling 8,425 shares during the quarter. New York State Common Retirement Fund owned approximately 0.71% of Definitive Healthcare worth $2,206,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Several other institutional investors have also recently made changes to their positions in DH. Cerity Partners LLC purchased a new stake in shares of Definitive Healthcare during the 1st quarter worth $56,000. Palisade Capital Management LP boosted its stake in shares of Definitive Healthcare by 1.3% in the first quarter. Palisade Capital Management LP now owns 2,265,198 shares of the company’s stock worth $6,546,000 after buying an additional 29,774 shares during the last quarter. Teacher Retirement System of Texas purchased a new stake in Definitive Healthcare in the 1st quarter worth approximately $376,000. Baker Tilly Wealth Management LLC increased its stake in shares of Definitive Healthcare by 19.2% in the 1st quarter. Baker Tilly Wealth Management LLC now owns 60,080 shares of the company’s stock valued at $174,000 after purchasing an additional 9,680 shares in the last quarter. Finally, Western Wealth Management LLC acquired a new position in shares of Definitive Healthcare during the 4th quarter worth approximately $90,000. Hedge funds and other institutional investors own 98.67% of the company’s stock.

Definitive Healthcare Stock Up 3.4%

DH stock opened at $4.24 on Thursday. The stock has a market cap of $630.23 million, a price-to-earnings ratio of -0.97, a price-to-earnings-growth ratio of 6.90 and a beta of 1.64. The company has a current ratio of 1.75, a quick ratio of 1.75 and a debt-to-equity ratio of 0.37. Definitive Healthcare Corp. has a 1-year low of $2.15 and a 1-year high of $6.16. The company’s 50 day moving average is $3.71 and its 200 day moving average is $3.64.

Definitive Healthcare (NASDAQ:DH) last issued its quarterly earnings data on Thursday, May 8th. The company reported $0.05 EPS for the quarter, topping the consensus estimate of $0.02 by $0.03. The company had revenue of $59.19 million during the quarter, compared to analyst estimates of $56.20 million. Definitive Healthcare had a positive return on equity of 3.69% and a negative net margin of 206.05%. Definitive Healthcare’s revenue was down 6.8% compared to the same quarter last year. During the same quarter in the previous year, the company posted $0.08 earnings per share. Sell-side analysts predict that Definitive Healthcare Corp. will post 0.16 EPS for the current fiscal year.

Wall Street Analyst Weigh In

DH has been the subject of a number of recent analyst reports. Wall Street Zen raised Definitive Healthcare from a “hold” rating to a “buy” rating in a report on Saturday, June 21st. BTIG Research cut shares of Definitive Healthcare from a “buy” rating to a “neutral” rating in a research note on Friday, May 9th. Finally, The Goldman Sachs Group raised their price target on Definitive Healthcare from $3.00 to $3.40 and gave the company a “neutral” rating in a report on Monday, May 12th. Two equities research analysts have rated the stock with a sell rating, seven have issued a hold rating and two have assigned a buy rating to the company’s stock. According to MarketBeat.com, the stock presently has a consensus rating of “Hold” and an average price target of $5.10.

About Definitive Healthcare

Definitive Healthcare Corp., together with its subsidiaries, provides software as a service (SaaS) healthcare commercial intelligence platform in the United States and internationally. Its SaaS platform provides information on healthcare providers and their activities to help its customers from product development to go-to-market planning, and sales and marketing execution.